"According to the National Health Service Breast Screening Programme (NHS BSP), these are called lesions of uncertain malignant potential (B3), including those with epithelial atypia 11,13."
"According to the National Health Service Breast Screening Programme (NHS BSP), these are called lesions of uncertain malignant potential (B3), including those with epithelial atypia 11,13."
"Management of B3 lesions is being de-escalated. The 2024 EUSOMA guidelines and the Third International Consensus accept vacuum-assisted excision instead of open excision for radial scar, flat epithelial atypia, papillary lesions and classic lobular neoplasia when there is radiopathological concordance 7,10. Atypical ductal hyperplasia is the exception, with a pooled upgrade rate of 29%, so surgery remains standard 7,12. Under the NHS BSP, women not upgraded at vacuum-assisted excision return to routine screening rather than annual mammography 11,13."
"Management of B3 lesions is being de-escalated. The 2024 EUSOMA guidelines and the Third International Consensus accept vacuum-assisted excision instead of open excision for radial scar, flat epithelial atypia, papillary lesions and classic lobular neoplasia when there is radiopathological concordance 7,10. Atypical ductal hyperplasia is the exception, with a pooled upgrade rate of 29%, so surgery remains standard 7,12. Under the NHS BSP, women not upgraded at vacuum-assisted excision return to routine screening rather than annual mammography 11,13."
"Management of B3 lesions is being de-escalated. The 2024 EUSOMA guidelines and the Third International Consensus accept vacuum-assisted excision instead of open excision for radial scar, flat epithelial atypia, papillary lesions and classic lobular neoplasia when there is radiopathological concordance 7,10. Atypical ductal hyperplasia is the exception, with a pooled upgrade rate of 29%, so surgery remains standard 7,12. Under the NHS BSP, women not upgraded at vacuum-assisted excision return to routine screening rather than annual mammography 11,13."
"According to the National Health Service Breast Screening Programme (NHS BSP), these are called lesions of uncertain malignant potential (B3), including those with epithelial atypia 11,13."
"According to the National Health Service Breast Screening Programme (NHS BSP), these are called lesions of uncertain malignant potential (B3), including those with epithelial atypia 11,13."